222 related articles for article (PubMed ID: 16518957)
61. Assessment of mitochondrial toxicity by analysis of mitochondrial protein expression in mononuclear cells.
Lin CH; Sloan DD; Dang CH; Wagner T; Cabrera AJ; Tobin NH; Frenkel LM; Jerome KR
Cytometry B Clin Cytom; 2009 May; 76(3):181-90. PubMed ID: 18823003
[TBL] [Abstract][Full Text] [Related]
62. In vitro analysis of synergism and antagonism of different nucleoside/nucleotide analogue combinations on the inhibition of human immunodeficiency virus type 1 replication.
Perez-Olmeda M; Garcia-Perez J; Mateos E; Spijkers S; Ayerbe MC; Carcas A; Alcami J
J Med Virol; 2009 Feb; 81(2):211-6. PubMed ID: 19107982
[TBL] [Abstract][Full Text] [Related]
63. The antiretroviral 2',3'-dideoxycytidine causes mitochondrial dysfunction in proliferating and differentiated HepaRG human cell cultures.
Young CKJ; Wheeler JH; Rahman MM; Young MJ
J Biol Chem; 2021; 296():100206. PubMed ID: 33334881
[TBL] [Abstract][Full Text] [Related]
64. Mitochondrial and Oxidative Stress Response in HepG2 Cells Following Acute and Prolonged Exposure to Antiretroviral Drugs.
Nagiah S; Phulukdaree A; Chuturgoon A
J Cell Biochem; 2015 Sep; 116(9):1939-46. PubMed ID: 25740676
[TBL] [Abstract][Full Text] [Related]
65. Estradiol attenuates mitochondrial depolarization in polyol-stressed lens epithelial cells.
Flynn JM; Cammarata PR
Mol Vis; 2006 Apr; 12():271-82. PubMed ID: 16617294
[TBL] [Abstract][Full Text] [Related]
66. Partial immunological and mitochondrial recovery after reducing didanosine doses in patients on didanosine and tenofovir-based regimens.
Negredo E; Garrabou G; Puig J; Lòpez S; Morén C; Bellido R; Ayen R; Cardellach F; Miró O; Clotet B
Antivir Ther; 2008; 13(2):231-40. PubMed ID: 18505174
[TBL] [Abstract][Full Text] [Related]
67. Site specific alterations of adipose tissue mitochondria in 3'-azido-3'-deoxythymidine (AZT)-treated rats: an early stage in lipodystrophy?
Deveaud C; Beauvoit B; Hagry S; Galinier A; Carrière A; Salin B; Schaeffer J; Caspar-Bauguil S; Fernandez Y; Gordien JB; Breilh D; Penicaud L; Casteilla L; Rigoulet M
Biochem Pharmacol; 2005 Jul; 70(1):90-101. PubMed ID: 15894294
[TBL] [Abstract][Full Text] [Related]
68. Improvements in lipoatrophy, mitochondrial DNA levels and fat apoptosis after replacing stavudine with abacavir or zidovudine.
McComsey GA; Paulsen DM; Lonergan JT; Hessenthaler SM; Hoppel CL; Williams VC; Fisher RL; Cherry CL; White-Owen C; Thompson KA; Ross ST; Hernandez JE; Ross LL
AIDS; 2005 Jan; 19(1):15-23. PubMed ID: 15627029
[TBL] [Abstract][Full Text] [Related]
69. Update on mitochondrial toxicity: where are we now?
Walker UA
J HIV Ther; 2003 May; 8(2):32-5. PubMed ID: 12838162
[TBL] [Abstract][Full Text] [Related]
70. HIV antiretroviral drug combination induces endothelial mitochondrial dysfunction and reactive oxygen species production, but not apoptosis.
Jiang B; Hebert VY; Li Y; Mathis JM; Alexander JS; Dugas TR
Toxicol Appl Pharmacol; 2007 Oct; 224(1):60-71. PubMed ID: 17669453
[TBL] [Abstract][Full Text] [Related]
71. Cellular and mitochondrial toxicity of zidovudine (AZT), didanosine (ddI) and zalcitabine (ddC) on cultured human muscle cells.
Benbrik E; Chariot P; Bonavaud S; Ammi-Saïd M; Frisdal E; Rey C; Gherardi R; Barlovatz-Meimon G
J Neurol Sci; 1997 Jul; 149(1):19-25. PubMed ID: 9168161
[TBL] [Abstract][Full Text] [Related]
72. Long-term exposure to AZT, but not d4T, increases endothelial cell oxidative stress and mitochondrial dysfunction.
Kline ER; Bassit L; Hernandez-Santiago BI; Detorio MA; Liang B; Kleinhenz DJ; Walp ER; Dikalov S; Jones DP; Schinazi RF; Sutliff RL
Cardiovasc Toxicol; 2009 Mar; 9(1):1-12. PubMed ID: 19067249
[TBL] [Abstract][Full Text] [Related]
73. Combined effect of C-reactive protein and stavudine on adipogenesis.
Stankov MV; Schmidt RE; Behrens GM
Antivir Ther; 2009; 14(6):819-29. PubMed ID: 19812444
[TBL] [Abstract][Full Text] [Related]
74. Mitochondrial DNA depletion and morphologic changes in adipocytes associated with nucleoside reverse transcriptase inhibitor therapy.
Nolan D; Hammond E; Martin A; Taylor L; Herrmann S; McKinnon E; Metcalf C; Latham B; Mallal S
AIDS; 2003 Jun; 17(9):1329-38. PubMed ID: 12799554
[TBL] [Abstract][Full Text] [Related]
75. Mitochondrial and metabolic effects of nucleoside reverse transcriptase inhibitors (NRTIs) in mice receiving one of five single- and three dual-NRTI treatments.
Note R; Maisonneuve C; Lettéron P; Peytavin G; Djouadi F; Igoudjil A; Guimont MC; Biour M; Pessayre D; Fromenty B
Antimicrob Agents Chemother; 2003 Nov; 47(11):3384-92. PubMed ID: 14576092
[TBL] [Abstract][Full Text] [Related]
76. Guggulsterone inhibits adipocyte differentiation and induces apoptosis in 3T3-L1 cells.
Yang JY; Della-Fera MA; Baile CA
Obesity (Silver Spring); 2008 Jan; 16(1):16-22. PubMed ID: 18223606
[TBL] [Abstract][Full Text] [Related]
77. Nucleoside reverse transcriptase inhibitors, mitochondrial DNA and AIDS therapy.
Lewis W
Antivir Ther; 2005; 10 Suppl 2():M13-27. PubMed ID: 16152703
[TBL] [Abstract][Full Text] [Related]
78. A brief overview of mechanisms of mitochondrial toxicity from NRTIs.
Kohler JJ; Lewis W
Environ Mol Mutagen; 2007; 48(3-4):166-72. PubMed ID: 16758472
[TBL] [Abstract][Full Text] [Related]
79. Assessment of mitochondrial toxicity in human cells treated with tenofovir: comparison with other nucleoside reverse transcriptase inhibitors.
Birkus G; Hitchcock MJ; Cihlar T
Antimicrob Agents Chemother; 2002 Mar; 46(3):716-23. PubMed ID: 11850253
[TBL] [Abstract][Full Text] [Related]
80. Anti-human immunodeficiency virus type 1 therapy and peripheral neuropathy: prevention of 2',3'-dideoxycytidine toxicity in PC12 cells, a neuronal model, by uridine and pyruvate.
Keilbaugh SA; Hobbs GA; Simpson MV
Mol Pharmacol; 1993 Oct; 44(4):702-6. PubMed ID: 8232219
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
